The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

 
Web www.patentalert.com

< Methods and compositions for treating amyloid-related diseases

< Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

> Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

> Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
~ 00293